IHS Chemical Week

World News and Views :: Projects

Lonza Expands Viral-Based Therapeutics Business with New cGMP Unit at Houston

2:15 AM MDT | May 18, 2011 | Natasha Alperowicz

Lonza says it will expand its viral-based therapeutics business with the construction of a new cGMP clean room adjacent to its existing Houston operations. The facility will offer large-scale capacity to support late-stage viral vaccine and gene therapy projects. It will use disposable process systems and be able to support production anf fill/finish operations of up to 2,000 liters. Enhanced, EU compliant, fill and finish capabilities are in high demand from Lonza's pharma and biotech customers, the company says. The expansion will also reduce Lonza's clients'...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa